SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

BABA is facing significant downward pressure following allegations from Anthropic regarding illicit model extraction, fueling community concerns over geopolitical and regulatory risks. While some investors view the current price as a long-term value opportunity, sentiment remains polarized as many traders express frustration over the stock's persistent decline and potential delisting risks.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as shares face a sharp sell-off, with investors raising concerns about the company's leveraged Bitcoin strategy and potential dividend obligations. Discussions are dominated by speculation regarding a possible class-action investigation, contrasting arguments over whether this decline represents a generational buying opportunity or a structural death spiral.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing explosive, momentum-driven gains as investors bet on a persistent NAND flash supply supercycle fueled by relentless AI infrastructure demand. While the stock continues to hit record highs following positive industry earnings, the community remains sharply divided between those riding the historic rally and others warning of extreme overvaluation and inevitable mean reversion.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending as investors debate the impact of AI on its core design platform, with bullish community members highlighting recent product enhancements, strong revenue growth, and an optimistic analyst initiation despite the stock's recent downtrend. Bears and shorts remain active, however, citing concerns over market competition, intense selling pressure, and skepticism regarding the company's long-term profitability.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys is drawing intense retail attention as investors debate its potential as an undervalued asset versus a short-squeeze target, with the community actively tracking high volume and institutional short interest. While bulls focus on solid fundamentals and potential buyout catalysts, others caution that the current price action reflects the volatility common in social-media-driven trading environments.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors interpret a recent 8-K regulatory filing as strategic preparation for a potential acquisition, fueling massive speculative volume. The community is actively discussing this potential buyout alongside high short-interest dynamics, with many investors anticipating an imminent clinical milestone that could act as a catalyst for a further price breakout.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF (MAGS) is facing downward pressure and heightened volatility as traders weigh the impact of shifting market leadership, high capital expenditure concerns, and shifting institutional flows away from mega-cap tech. Community discussion centers on whether the current price action represents a healthy sector rotation into industrials and small-caps or a sign of structural weakness, with many market participants actively debating the sustainability of the AI infrastructure trade.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is facing heavy downward pressure as traders debate the sustainability of its high valuation amid a broader software sector selloff. While some community members view the dip as a generational buying opportunity for the AI-focused leader, many others are actively discussing a recent shift in positioning by high-profile short sellers and the risk of further volatility as the stock tests critical technical support levels.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma (HELP) is experiencing significant volatility and downward pressure following the release of Phase 2 data for its HLP004 anxiety program, which investors are weighing against its Breakthrough Therapy-designated HLP003 pipeline. Community sentiment is deeply divided as the stock trades near cash value, with active discussions debating whether this is a distressed entry point for a sector buyout or a sign of deeper management and financial risks.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is currently attracting significant retail and institutional interest, fueled by unconfirmed M&A chatter and heavy call option activity that some traders believe could lead to a short squeeze. Despite this speculative momentum, the community remains divided, with long-term shareholders expressing frustration over stagnant price action and past manufacturing delays while others closely monitor potential upcoming clinical catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SGMO I will give biotech credit he is pumping til the bitter end.  
 
 
 
Phoenix Biotech 
@BiotechAnalysst 
· 
58m 
Replying to  
@TheCryptoMaze 
$SGMO we still own NAV.17 after this 
 
&quot;clinical-stage ST-503 program to treat chronic neuropathic pain,   re  
$VRTX 
  
 
the  giroctocogene fitelparvovec program to treat hemophilia A, and  
 
Sangamo’s  cell therapy and regulatory T cell (#Treg) assets&quot; #nobelprize

StockTwits Web

Sangamo Therapeutics Inc

Vertex Pharmaceuticals, Inc.

 I will give biotech credit he is pumping til the bitter end.  
 
 
 
Phoenix Biotech 


 we still own NAV.17 after this 
 
"clinical-stage ST-503 program to treat chronic neuropathic pain,   re  


 
  
 
the  giroctocogene fitelparvovec program to treat hemophilia A, and  
 
Sangamo’s  cell therapy and regulatory T cell (

Pete Sidders

@Patrick2343 @BiotechAnalysst @TheCryptoMaze Yes credit where it&#39;s due but he is right to a degree.  We are all assigning zero value as we assess different valuations and what crumbs might be left for us.  No sugarcoating this disaster but hoping for a few crumbs left over for us.

StockTwits for iOS

 Yes credit where it's due but he is right to a degree.  We are all assigning zero value as we assess different valuations and what crumbs might be left for us.  No sugarcoating this disaster but hoping for a few crumbs left over for us.